Immunodiagnostic Systems Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Immunodiagnostic Systems Holdings generated cash of $5,543,000, which is more than the previous year. Cash used in financing activities reached the amount of -$938,000 last year. Net change in cash is therefore -$129,000.
Cash Flow
| 2010 | 9.91M | -6.92M | -2.16M |
|---|---|---|---|
| 2011 | 16.39M | -9.87M | -5.43M |
| 2012 | 13.76M | -6.59M | -2.06M |
| 2016 | 8.18M | -4.82M | -985K |
| 2018 | 2.51M | -3.87M | -1.40M |
| 2020 | 5.54M | -4.66M | -938K |
IDH.L Cash Flow Statement (2010 – 2019)
| 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 27.71M | 31.49M | 23.73M | 6.36M | 5.27M | 4.45M |
Operating activities | ||||||
Net income | 3.34M | 1.22M | -32.17M | 4.73M | 12.99M | 8.07M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 4.72M | 4.56M | 6.98M | 6.56M | 3.81M | 3.35M |
Stock-based compensation expense | 0 | 0 | 0 | 214K | 369K | 355K |
| Deferred income tax benefit | 0 | 0 | 0 | 214K | 369K | 355K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -2.48M | -759K | -350K | 706K | -2.12M | -869K |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 5.54M | 2.51M | 8.18M | 13.76M | 16.39M | 9.91M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4.83M | -3.99M | -5.18M | -6.83M | -8.18M | -6.97M |
Acquisitions Net | 0 | 0 | 0 | -593K | -1.90M | -213K |
Cash generated by investing activities | -4.66M | -3.87M | -4.82M | -6.59M | -9.87M | -6.92M |
Financing activities | ||||||
Common Stock Issued | 0 | 83K | 410K | 696K | 74K | 816K |
Payments for dividends | 0 | 0 | 0 | -708K | -559K | -436K |
Repurchases of common stock | 0 | -147K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -2.02M | -4.89M | -2.44M |
Cash used in financing activities | -938K | -1.40M | -985K | -2.06M | -5.43M | -2.16M |
Net Change In Cash | -129K | -2.96M | 2.82M | 4.66M | 1.08M | 820K |
Cash at end of period | 27.58M | 28.53M | 26.55M | 11.03M | 6.36M | 5.27M |
| Data source | Data source | Data source |